Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Avidity Biosciences, Inc. (RNA)
Sector: Healthcare; Industry: Biotechnology

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It utilizes its proprietary AOC platform to design, engineer, and develop therapeutics that combine tissue selectivity of monoclonal antibodies and precision of oligonucleotide therapies to access previously undruggable tissue and cell types, and target underlying genetic drivers of diseases. The company also has development programs that focuses on immune and other cell types.

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-03-16 LEVIN ARTHUR A Chief Scientific Officer Sell 4,600 $27.87 $128,181 Yes
2020-06-16 Cormorant Asset Management, LP Former 10% Owner Buy 300,000 $18.00 $5,400,000 Yes
2020-06-16 RTW INVESTMENTS, LP 10%-Owner Buy 950,000 $18.00 $17,100,000 Yes

Insider Smart

CARNIVAL CORP (CCL) - Cruislines $CCL $NCLH $RCL took a huge beat due to the pandemic, concerns of bankruptcy were raised. Among the three dominating companies in the industry, $CCL is the first one bought by insiders, such a bold move would definitely boost investor confidence.

Insider Smart

SERVICE CORP INTERNATIONAL (SCI) - WALTRIP W BLAIR, Director of $SCI made a buy at 34.65, was he convinced the bottom of the box is a strong support? Well, seems he is not wrong.